National Landscape of Hemorrhagic Myocardial Infarction in the United States

Prevalence of Hemorrhagic Myocardial Infarction in the United States

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06162039

Acronym

MIRON-NATIONAL

Enrollment

24181

Registered

2023-12-08

Start date

2023-12-13

Completion date

2025-03-15

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Brief summary

Registry analysis for prevalence of hemorrhagic myocardial infarction in the United States

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Acute Myocardial Infarction - STEMI Primary PCI Availability of lab parameters and/or CMR

Design outcomes

Primary

Measure	Time frame	Description
Statewise proportion of Hemorrhagic Myocardial Infarction in the United States	10 years	Prevalence of Hemorrhagic Myocardial Infarction

Secondary

Measure	Time frame	Description
Statewise proportion of Acute Heart Failure in Hemorrhagic Myocardial Infarction	30 days	Prevalence of Acute Heart Failure in Hemorrhagic Myocardial Infarction
Statewise proportion of re-hospitalization in Hemorrhagic Myocardial Infarction	30 days	Prevalence of re-hospitalization in Hemorrhagic Myocardial Infarction
Statewise proportion of arrhythmia in Hemorrhagic Myocardial Infarction	30 days	Prevalence of arrhythmia in Hemorrhagic Myocardial Infarction

Countries

United States

Outcome results